Published in Women's Health Weekly, July 25th, 2002
Tamoxifen therapy for 5 years after surgery is the established treatment for postmenopausal women with hormone-sensitive breast cancer. However, its use is associated with several side effects, including endometrial cancer and blood-clotting disorders. The ATAC investigators led by Michael Baum from University College London, U.K., and colleagues was an international study that aimed to compare the safety and efficacy of tamoxifen with anastrozole alone and the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly